ResMed Inc.

NYSE:RMD

Medical - Devices

Healthcare
$242.61 +0.85%

+$1.58 today

Market cap
$34.12B
Beta
0.78
P/E (TTM)
18.1
EPS (TTM)
$10.37
Dividend yield
1.28%
52W Low $180.27High $293.81

Volume 1.22M

Average 1.32M

RMD Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

ResMed Inc.NYSE: RMD

Deferred Revenue · Q4 FY2026 · quarter ended Jun 2026

Deferred revenue broadly unchanged from a year ago

Deferred revenue stood at $162.91M at the end of Q4 FY2026, down 1.9% from a year earlier and down 9.1% from the prior quarter. Over 3 fiscal years it compounded at +5.7% a year.

Context

  • Deferred revenue amounted to 1.8% of total assets at the end of Q4 FY2026, down 0.2 pp from a year earlier.
  • Deferred revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether deferred revenue keeps falling in the next quarterly balance sheet after a -1.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$162.91M-9.1% QoQ
Last fiscal yearJun 2026
$162.91M-1.9% YoY
Year agoJun 2025
$166.03M-1.9% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.9%——
1 year-1.9%——
3-year CAGR+5.7%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2026
162.91M USD
Year-over-year change
-1.9%
4-year CAGR
+10.7%

Deferred Revenue vs competitors

How RMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred revenue is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -1.9% is the 4th highest of 5, against a peer median of +5.4%.
  • Deferred revenue amounts to 1.8% of total assets for RMD, versus a peer median of 0.0%.
RMD Competitors
Deferred Revenue for RMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GEHCGE HealthCare Technologies Inc.Jun 2026$2.2B USD+11.2%—5.9%
PHGKoninklijke Philips N.V.Jun 2026€1.58B EUR+0.6%—5.9%
ISRGIntuitive Surgical, Inc.Sep 2026$541.2M USD+10.2%+8.4%2.8%
RMDResMed Inc.Jun 2026$162.91M USD-1.9%+5.7%1.8%
MDTMedtronic plcJul 2026$0 USD——0.0%
BSXBoston Scientific CorporationJun 2026$0 USD-100.0%+12.5%0.0%
TFXTeleflex IncorporatedJun 2026$0 USD——0.0%
INSPInspire Medical Systems, Inc.Jun 2026$0 USD——0.0%
ELMDElectromed, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding RMD) —+5.4%+10.5%0.0%

Competitors are the stored peer set for RMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Cash & Equivalents273.71M227.89M238.36M1.21B1.47B
Short-term Investments00000
Net Receivables575.95M704.91M837.28M990.67M1.04B
Inventory743.91M998.01M822.25M927.71M945.81M
Other Current Assets131.27M179.93M180.01M164.5M457.39M
Total Current Assets1.93B2.37B2.36B3.51B4.32B
Property, Plant & Equipment (Net)630.5M665.81M699.15M718.29M735M
Goodwill1.94B2.77B2.84B3.05B3.36B
Intangible Assets345.94M552.34M485.9M464.86M0
Long-term Investments67.22M156.89M169.77M85.03M0
Tax Assets79.75M132.97M203.57M253.12M543.9M
Other Non-current Assets104.53M105.56M114.24M100.81M0
Total Non-current Assets3.16B4.38B4.51B4.67B4.64B
Total Assets5.1B6.75B6.87B8.17B8.97B
Account Payables159.25M150.76M237.73M278.16M308.92M
Short-term Debt9.92M9.9M9.9M9.9M259.95M
Tax Payables44.89M72.22M107.52M098.11M
Deferred Revenue108.67M138.07M152.55M166.03M162.91M
Other Current Liabilities1.95M9.56M4.65M2.7M41.16M
Total Current Liabilities689.3M758.53M910.66M1.02B1.4B
Long-term Debt765.33M1.43B697.31M658.39M399.42M
Deferred Tax Liabilities9.71M90.65M79.34M77.68M64.64M
Deferred Revenue (Non-current)95.46M119.19M137.34M156.8M170.95M
Other Non-current Liabilities54.86M105.35M42.26M141.52M213.03M
Total Non-current Liabilities1.05B1.86B1.1B1.19B985.45M
Total Liabilities1.74B2.62B2.01B2.21B2.38B
Common Stock586K588K588K761K764K
Retained Earnings3.61B4.25B4.99B6.08B7.26B
Accumulated OCI(312.75M)(272.53M)(251.53M)(74.7M)(82.52M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.36B4.13B4.86B5.97B6.59B
Total Debt917.55M1.58B873.94M851.81M825.92M
Net Debt643.84M1.35B635.57M(357.64M)(643.32M)

ResMed Inc.

NYSE:RMD

Intrinsic Alpha fair value

Locked

Current Price

$242.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.